Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Gene-gene Interaction in Cerebral Infarction Patients : A Study on Relationship Between Apolipoprotein E, ACE Gene Polymorphism and Sasang Constitution

  • Kim Jong Kwan (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kim Hyoung Soon (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Bae Young Chun (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee Sang Min (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kim Kyung Yo (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Joo Jong Cheon (Department of Sasang Constitutional Medicine, College of Oriental Medicine, Wonkwang University)
  • Published : 2004.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sasang Constitutional Medicine is a major branch of Korean Traditional Medicine. The differences of disease susceptibility to be shown in Sasang constitution may be due to genetic factors. Therefore, I examined interrelationship among cerebral infarction (CI), apolipoprotein E (apo E) gene polymorphism, and Sasang constitutional classification. Apo E is a key protein modulating the highly atherogenic apoB containing lipoproteins and is a candidate gene for the development of coronary artery disease (CAD). The ε2 and/or ε4 alleles were the first to be implicated in premature CAD, which resulted in this polymorphism being extensively studied. I investigated the association between apo E genotype and CI by case-control study in a Korean population. I also classified CI patients and control group into groups according to Sasang Constitutional Medicine. 218 CI patients and 379 controls without CI were examined. Apo E genotype was determined by 8% polyacrylamide gel separation after DNA amplification. A frequency of apo E ε3/ε3 in the apo E genotype distribution was higher in the CI patients compared with that in controls. Also, it was widely known that Taeumin was easily attacked with CI, but there was no association between apo E polymorphim and Taeumin. However, the Taeumin constitution did not enhance the relative risk for CI in the subjects with apo E ε2 and/or ε4 alleles. No differences in the apo E genotypes frequencies were observed in the Taeumin compared with that in the other constitutions. In addition, I investigated whether the DD(deletion/deletion) or ID(insertion/deletion) genotype of angiotensin converting enzyme (ACE) gene, a candidate gene for CI, was associated with CI, Taeumin constitution, and apo E polymorphism. As a result, the frequency of Taeumin constitution was significantly higher in CI patients with both apo E ε3/ε4 and ACE ID/DD genotypes than in the remaining Sasang constitutions. In summary, it was concluded that the apo E polymorphism is a major risk factor for CI in Koreans and the ACE ID/DD genotype enhanced the relative risk for CI in the subjects with apo E ε3/ε4 genotype and Taeumin constitution.

Keywords

References

  1. Longevity & Life Preservation In Oriental Medicine Lee JM;Choi SH(ed)
  2. Clin Chem v.41 Apolipoprotein E: an important gene and protein to follow in laboratory medicine Siest G;Pillot T;Regis-Bailly A;Leininger-Muller B;Steinmetz J;Galteau MM;Visvikis S
  3. Atherosclerosis v.8 Apolipoprotein E polymorphism and atherosclerosis Davignon J;Gregg RE;Sing CF
  4. Hypertension v.18 Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin Wiemer G;Scholkens BA;Becker RH;Busse R
  5. J Hypertens v.13 Lack of association between angiotensin converting enzyme and gene insertion/deletion polymorphism and stroke Ueda S;Weir CJ;Inglis GC;Murray GD;Muir KW;Lees KR
  6. J Clin Invest v.86 An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels Rigat B;Hubert C;Alhenc-Gelas F;Cambien F;Corvol P;Soubrier F
  7. Am J Hum Genet v.51 Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme(ACE) gene controls plasma ACE levels Tiret L;Rigat B;Visvikis S;Breda C;Corvol P;Cambien F;Soubrier F
  8. Am J Cardiol v.81 Angiotensin-converting enzyme gene polymorphism in systemic hypertension Abbud ZA;Wilson AC;Cosgrove NM;Kostis JB
  9. Am J Cardiol v.82 Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism Ledru F;Blanchard D;Battaglia S;Jeunemaitre X;Courbon D;Guize L;Guermonprez JL;Ducimetiere P;Diebold B
  10. Clin Nephrol v.51 The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure I IDDM Vleming LJ;van der Pijl JW;Lemkes HH;Westendorp RG;Maassen JA;Daha MR;van Es LA;van Kooten C
  11. J Thromb Thrombolysis v.5 Angiotensin-converting enzyme gene polymorphism and plasminogen activator inhibitor 1 levels in subjects with cerebral infarction Seino Y;Ikeda U;Maeda Y;Haga Y;Yashima H;Shimada K
  12. J Hum Hypertens v.8 Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme Sharma P;Carter ND;Barley J;Brown MM
  13. Stroke v.26 Angiotensin-converting enzyme gene deletion polymorphism-A new risk factor for lacunar stroke but not carotid atheroma Markus HS;Barley J;Lunt R;Bland JM;Jeffery S;Carter ND;Brown MM
  14. Circulation v.93 Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives Kario K;Kanai N;Saito K;Nago N;Matsuo T;Shimada K
  15. Nucleic Acids Res v.16 A simple salting out procedure for extracting DNA from human nucleated cells Miller SA;Dykes DD;Polesky HF
  16. Arterioscler Thromb v.11 Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphism affects atherosclerosis in young males Hixon JE
  17. Genomics v.3 Genotyping and sequence analysis of apolipoprotein E isoforms Emi M;Wu LL;Robertson MA;Myers RL;Hegele RA;Williams RR;White R;Lalouel JM
  18. Q J Med v.87 Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease Evans AE;Poirier O;Kee F;Lecerf L;McCrum E;Falconer T;Crane J;O'Rourke DF;Cambien F
  19. Trans Roy Soc v.52 The correlation between relatives under the supposition of mendelian inheritance Fisher RA
  20. Introduction to Quantitative Genetics Falconer DS.
  21. Stroke v.26 Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients Kosunen O;Talasniemi S;Lehtovirta M;Heinonen O;Helisalmi S; Mannermaa A;Paljarvi L;Ryynanen M;Riekkinen PSr.;Soininen H
  22. Arterioscler Thromb Vasc Biol v.15 Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography Wang XL;McCredie RM;Wilcken DE
  23. Stroke v.23 Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism Pedro-Botet J;Senti M;Nogues X;Rubies-Prat J;Roquer J;D'Olhaberriague L;Olive J
  24. Stroke v.24 Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimer's disease Couderc R;Mahieux F;Bailleul S
  25. Arterioscler Thromb Vasc Biol v.15 Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects Kuusisto J;Mykkanen L;Kervinen K;Kesaniemi YA;laakso M
  26. Am J Hypertens v.10 Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease Nakata Y;Katsuya T;Rakugi H;Takami S;Sato N;Kamide K;Ohishi M;Miki T;Higaki J;Ogihara T
  27. Neurology v.53 APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis McCarron MO;Delong D;Alberts MJ
  28. Acta Neurol Scand v.101 Apolipoprotein E polymorphism in cerebrovascular disease Catto AJ;McCormack LJ;Mansfield MW;Carter AM;Bamford JM;Robinson P;Grant PJ
  29. Neurology v.56 APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease Frikke-Schmidt R;Nordestgaard BG;Thudium D;Moes Gronholdt ML;Tybjaerg-Hansen A
  30. Eur J Clin Invest v.31 Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population MacLeod MJ;De Lange RP;Breen G;Meiklejohn D;Lemmon H;Clair DS
  31. Lancet v.348 Beta 3-adrenergic receptor gene variant and Japanese NIDDM: a pitfall in meta-analysis Odawara M;Sasaki K;Yamashita K
  32. Arterioscler Thromb Vasc Biol v.17 Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study Zaman MM;Ikemoto S;Yoshiike N;Date C;Yokoyama T;Tanaka H
  33. Stroke v.31 Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population Kokubo Y;Chowdhury AH;Date C;Yokoyama T;Sobue H;Tanaka H
  34. Hum Biol v.74 Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population Kumar T;Liestol K;Maehlen J;Hiorth A;Jettestuen E;Lind H;Brorson SH
  35. Hum Biol v.70 Genetic variability of apolipoprotein E in a Polish population Kowalska A;Wiechmann I;Walter H
  36. Hum Biol v.70 Study of 15 protein polymorphisms in a sample of the Turkish population Brega A;Scacchi R;Cuccia M;Kirdar B;Peloso G;Corbo RM
  37. Hum Biol v.74 Characterization of apolipoprotein E genetic variations in Taiwanese: association with coronary heart disease and plasma lipid levels Wu JH;Lo SK;Wen MS;Kao JT